However, there are very limited data to prove that MCP-1 levels are elevated in acute phase of an ischemic stroke and that can be used as an early predictor to distinguish stroke subtype and subjective etiology or to estimate the severity and the disease outcome. Here, CCL2 is linked to stroke disorder.